Logo Image
News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in MedicineShorts
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Emerging Pharma Leaders Awards|
Latest Executive Roundtables|
Asembia 2026|
Sales Effectiveness
Advertisement

Stephanie Brewer, PhD

Advertisement

Articles by Stephanie Brewer, PhD

How to Communicate About an Ongoing Epidemic of Historic Proportions

ByStephanie Brewer, PhD,Barbara Blasso
December 20th 2019

Pharmaceutical Executive

The industry faces a problem of medical education and communication in regards to vaccinations.

Advertisement

Latest Updated Articles

  • How to Communicate About an Ongoing Epidemic of Historic Proportions
    How to Communicate About an Ongoing Epidemic of Historic Proportions

    December 20th 2019



Advertisement
Advertisement

Trending on PharmExec

1

The Industry’s Communication and Engagement with FDA

2

Eli Lilly Enters $202 Million Agreement to Acquire Engage Bio

3

Pharma Roundup: Bristol Myers Squibb Enters Strategic Agreement with Anthropic, Incyte and Genesis Expand Strategic Collaboration

4

Pharmaceutical Executive Daily: Eli Lilly Acquires Engage Bio

5

The Difference Between Real-Time Clinical Data Review and Real-Time Clinical Trial Oversight

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us